analyticsVertical SaaS
Data as of Q4 2025
Summary Verdict
HNGE: 4—EGHT: 1wins
Rule of 40
79.6HNGE
8.5EGHT
check_circleHNGE leads
Revenue Growth
50.6%HNGE
0.1%EGHT
check_circleHNGE leads
Gross Margin
80%HNGE
67%EGHT
check_circleHNGE leads
FCF Margin
29.0%HNGE
8.4%EGHT
check_circleHNGE leads
Operating Margin
-92.9%HNGE
2.1%EGHT
check_circleEGHT leads
NRR
—HNGE
—EGHT
Metric
Rule of 40Efficiency score
HNGE
79.6check_circle
EGHT
8.5
Revenue GrowthYoY
HNGE
50.6%check_circle
EGHT
0.1%
Gross Margin% of revenue
HNGE
80%check_circle
EGHT
67%
FCF MarginFree cash flow
HNGE
29.0%check_circle
EGHT
8.4%
Operating MarginGAAP
HNGE
-92.9%
EGHT
2.1%check_circle
NRRNet retention
HNGE
N/A
EGHT
N/A
EV / RevenueValuation multiple
HNGE
N/A
EGHT
0.8x
Market CapUSD
HNGE
N/A
EGHT
$266.1M
ARR GrowthYoY
HNGE
N/A
EGHT
N/A
CAC PaybackMonths to recover
HNGE
N/A
EGHT
N/A
Advertisement
insights
Analysis
As of Q4 2025, Hinge Health, Inc. trades at N/A EV/Revenue versus 8X8 INC /DE/ at 0.8x. On the Rule of 40, Hinge Health, Inc. scores 79.6 compared to 8X8 INC /DE/'s 8.5, placing Hinge Health, Inc. ahead in operating efficiency. Gross margins stand at Hinge Health, Inc. 80% vs 8X8 INC /DE/ 67%.
Sector Context
Both companies operate in the Vertical SaaS sector. The median columns above show where each company stands relative to their peers.